Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 8
1996 6
1997 10
1998 2
1999 6
2000 3
2001 1
2002 1
2004 4
2005 3
2006 5
2007 3
2008 5
2009 3
2010 4
2011 7
2012 3
2013 3
2014 1
2015 2
2016 3
2017 1
2018 3
2020 3
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Resistance to Endocrine Therapies in Cancer.
Ranganathan P, Chakrabarty A, Hiscox S, Limaye AM, Vella V. Ranganathan P, et al. Among authors: hiscox s. Front Endocrinol (Lausanne). 2020 Apr 9;11:196. doi: 10.3389/fendo.2020.00196. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32328035 Free PMC article. No abstract available.
Editorial: Resistance to endocrine therapies in cancer, volume II.
Chakrabarty A, Hiscox S, Ranganathan P. Chakrabarty A, et al. Among authors: hiscox s. Front Endocrinol (Lausanne). 2024 Apr 23;15:1414392. doi: 10.3389/fendo.2024.1414392. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38715800 Free PMC article. No abstract available.
Pro-metastatic tumor-stroma interactions in breast cancer.
Gangadhara S, Barrett-Lee P, Nicholson RI, Hiscox S. Gangadhara S, et al. Among authors: hiscox s. Future Oncol. 2012 Nov;8(11):1427-42. doi: 10.2217/fon.12.134. Future Oncol. 2012. PMID: 23148616 Review.
From the Journals.
Evans W, Bretland A, Hiscox SJ, Chant D. Evans W, et al. Among authors: hiscox sj. J Wound Care. 1992 Nov 2;1(4):9-10. doi: 10.12968/jowc.1992.1.4.9. J Wound Care. 1992. PMID: 27911207
Therapeutic targeting of tumor-stroma interactions.
Hiscox S, Barrett-Lee P, Nicholson RI. Hiscox S, et al. Expert Opin Ther Targets. 2011 May;15(5):609-21. doi: 10.1517/14728222.2011.561201. Epub 2011 Mar 10. Expert Opin Ther Targets. 2011. PMID: 21388336 Review.
New therapeutic approaches in breast cancer.
Davies E, Hiscox S. Davies E, et al. Among authors: hiscox s. Maturitas. 2011 Feb;68(2):121-8. doi: 10.1016/j.maturitas.2010.10.012. Epub 2010 Dec 8. Maturitas. 2011. PMID: 21144683 Review.
Aromatase inhibitors in breast cancer.
Hiscox S, Davies EL, Barrett-Lee P. Hiscox S, et al. Maturitas. 2009 Aug 20;63(4):275-9. doi: 10.1016/j.maturitas.2009.05.008. Epub 2009 Jul 3. Maturitas. 2009. PMID: 19577386 Review.
Src inhibitors in breast cancer therapy.
Hiscox S, Nicholson RI. Hiscox S, et al. Expert Opin Ther Targets. 2008 Jun;12(6):757-67. doi: 10.1517/14728222.12.6.757. Expert Opin Ther Targets. 2008. PMID: 18479222 Review.
89 results